95 related articles for article (PubMed ID: 3678477)
1. A synthetic hemoregulatory peptide (HP5B) inhibits human myelopoietic colony formation (CFU-GM) but not leukocyte phagocytosis in vitro.
Laerum OD; Sletvod O; Bjerknes R; Paukovits WR
Eur J Haematol; 1987 Sep; 39(3):259-66. PubMed ID: 3678477
[TBL] [Abstract][Full Text] [Related]
2. Effects of a hemoregulatory peptide (HP5b) on erythroid and myelopoietic colony formation in vitro.
Kreja L; Hågå P; Muller-Bérat N; Laerum OD; Sletvold O; Paukovits WR
Scand J Haematol; 1986 Aug; 37(2):79-86. PubMed ID: 3764340
[TBL] [Abstract][Full Text] [Related]
3. The dimer of hemoregulatory peptide (HP5B) stimulates mouse and human myelopoiesis in vitro.
Laerum OD; Sletvold O; Bjerknes R; Eriksen JA; Johansen JH; Schanche JS; Tveterås T; Paukovits WR
Exp Hematol; 1988 May; 16(4):274-80. PubMed ID: 3258825
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of hemoregulatory peptide (HP5b) action in culture.
Laerum OD; Aakvaag A; Frostad S; Kalland T; Langen P; Maurer HR
Int J Cell Cloning; 1990 Nov; 8(6):431-44. PubMed ID: 2273297
[TBL] [Abstract][Full Text] [Related]
5. Hemoregulatory peptide (HP5b) dimer effects on normal and malignant cells in culture.
Frostad S; Kalland T; Aakvaag A; Laerum OD
Stem Cells; 1993 Jul; 11(4):303-11. PubMed ID: 8401253
[TBL] [Abstract][Full Text] [Related]
6. Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in mice.
Alisauskas RM; Goldenberg DM; Sharkey RM; Blumenthal RD
Int J Cancer; 1997 Jan; 70(3):323-9. PubMed ID: 9033635
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide.
Paukovits WR; Guigon M; Binder KA; Hergl A; Laerum OD; Schulte-Hermann R
Cancer Res; 1990 Jan; 50(2):328-32. PubMed ID: 2295072
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo.
Laerum OD; Paukovits WR
Exp Hematol; 1984 Jan; 12(1):7-17. PubMed ID: 6230248
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of enriched stem cells in vivo and in vitro by the hemoregulatory peptide SK&F108636.
Veiby OP; LoCastro S; Bhatnagar P; Olsen WM
Stem Cells; 1996 Mar; 14(2):215-24. PubMed ID: 8991541
[TBL] [Abstract][Full Text] [Related]
10. Indirect stimulation of hemopoiesis by hemoregulatory peptide (HP5b) dimer in murine long-term bone marrow cultures.
Veiby OP; Løvhaug D; Fjerdingstad H; Engelsen SJ
Exp Hematol; 1992 Feb; 20(2):192-5. PubMed ID: 1544388
[TBL] [Abstract][Full Text] [Related]
11. The sequence of the hemoregulatory peptide is present in Gi alpha proteins.
Laerum OD; Frostad S; Tøn HI; Kamp D
FEBS Lett; 1990 Aug; 269(1):11-4. PubMed ID: 2117550
[TBL] [Abstract][Full Text] [Related]
12. Adherent-cell-dependent stimulation of CFU-GM by nucleobases, nucleosides, their analogues, and the hemoregulatory peptide dimer.
Langen P; Schunck H; Hunger B; Schütt M; Laerum OD
Exp Hematol; 1992 Feb; 20(2):196-200. PubMed ID: 1544389
[TBL] [Abstract][Full Text] [Related]
13. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.
Pelus LM; King AG; Broxmeyer HE; DeMarsh PL; Petteway SR; Bhatnagar PK
Exp Hematol; 1994 Mar; 22(3):239-47. PubMed ID: 8112423
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood leukocyte alterations in mice induced by a hemoregulatory pentapeptide (HP 5b).
Laerum OD; Paukovits WR
Leuk Res; 1985; 9(8):1075-84. PubMed ID: 3840221
[TBL] [Abstract][Full Text] [Related]
15. Modulation of murine hemopoiesis in vivo by a synthetic hemoregulatory pentapeptide (HP 5b).
Laerum OD; Paukovits WR
Differentiation; 1984; 27(2):106-12. PubMed ID: 6548197
[TBL] [Abstract][Full Text] [Related]
16. The hemoregulatory peptide pEEDCK may inhibit stem cell proliferation via hydropathic binding to antisense sequence motifs in interleukin-11 and other growth factors.
Paukovits JB; Rutter R; Ganglberger E; Karlic HI; Marian B; Paukovits WR
Mol Pharmacol; 1999 Oct; 56(4):665-74. PubMed ID: 10496948
[TBL] [Abstract][Full Text] [Related]
17. Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide, HP-5.
King AG; Talmadge JE; Badger AM; Pelus LM
Exp Hematol; 1992 Feb; 20(2):223-8. PubMed ID: 1544391
[TBL] [Abstract][Full Text] [Related]
18. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
[TBL] [Abstract][Full Text] [Related]
19. Biological and chemical properties of the hemoregulatory peptide and possibilities for clinical applications.
Laerum OD; Paukovits WR
Pharmacol Ther; 1989; 44(3):335-49. PubMed ID: 2519347
[No Abstract] [Full Text] [Related]
20. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
